These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Adjuvant platinum-based chemotherapy for early stage cervical cancer. Rosa DD; Medeiros LR; Edelweiss MI; Pohlmann PR; Stein AT Cochrane Database Syst Rev; 2012 Jun; 6(6):CD005342. PubMed ID: 22696349 [TBL] [Abstract][Full Text] [Related]
23. Surgery for early stage cervical cancer: how radical should it be? Reade CJ; Eiriksson LR; Covens A Gynecol Oncol; 2013 Oct; 131(1):222-30. PubMed ID: 23863357 [TBL] [Abstract][Full Text] [Related]
24. Fertility sparing therapy in women with lymph node negative cervical cancer >2cm - oncologic and fertility outcomes of neoadjuvant chemotherapy followed by radical vaginal trachelectomy. Plaikner A; Siegler K; Hertel H; Jacob A; Petzel A; Schubert M; Blohmer JU; Böhmer G; Marnitz S; Ragosch V; Domröse C; Oppelt P; Jülicher A; Schneider A; Willems A; Favero G; Köhler C Int J Gynecol Cancer; 2023 Oct; 33(10):1542-1547. PubMed ID: 37696645 [TBL] [Abstract][Full Text] [Related]
25. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery. Bean LM; Ward KK; Plaxe SC; McHale MT Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318 [TBL] [Abstract][Full Text] [Related]
26. Open vs minimally invasive radical trachelectomy in early-stage cervical cancer: International Radical Trachelectomy Assessment Study. Salvo G; Ramirez PT; Leitao MM; Cibula D; Wu X; Falconer H; Persson J; Perrotta M; Mosgaard BJ; Kucukmetin A; Berlev I; Rendon G; Liu K; Vieira M; Capilna ME; Fotopoulou C; Baiocchi G; Kaidarova D; Ribeiro R; Pedra-Nobre S; Kocian R; Li X; Li J; Pálsdóttir K; Noll F; Rundle S; Ulrikh E; Hu Z; Gheorghe M; Saso S; Bolatbekova R; Tsunoda A; Pitcher B; Wu J; Urbauer D; Pareja R Am J Obstet Gynecol; 2022 Jan; 226(1):97.e1-97.e16. PubMed ID: 34461074 [TBL] [Abstract][Full Text] [Related]
27. Conization and lymph node evaluation in low-risk cervical cancer. Is it time to avoid radical surgery? Retrospective series and literature review. Lucchini SM; Ferreyra HD; Landeros J; Esteban A; Donetch G; Goldsman MG; Borla HF; Heredia F Eur J Obstet Gynecol Reprod Biol; 2021 Nov; 266():163-168. PubMed ID: 34673464 [TBL] [Abstract][Full Text] [Related]
28. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy. Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197 [TBL] [Abstract][Full Text] [Related]
36. Conservative surgery in early-stage cervical cancer: what percentage of patients may be eligible for conization and lymphadenectomy? Smith AL; Frumovitz M; Schmeler KM; dos Reis R; Nick AM; Coleman RL; Ramirez PT Gynecol Oncol; 2010 Nov; 119(2):183-6. PubMed ID: 20708227 [TBL] [Abstract][Full Text] [Related]
38. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy. Yanaranop M; Sathapornteera N; Nakrangsee S J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S87-95. PubMed ID: 25509701 [TBL] [Abstract][Full Text] [Related]
39. Type II or type III radical hysterectomy compared to chemoradiotherapy as a primary intervention for stage IB2 cervical cancer. Nama V; Angelopoulos G; Twigg J; Murdoch JB; Bailey J; Lawrie TA Cochrane Database Syst Rev; 2018 Oct; 10(10):CD011478. PubMed ID: 30311942 [TBL] [Abstract][Full Text] [Related]
40. [Radical hysterectomy with pelvic lymphadenectomy in patients with carcinoma of the uterine cervix--3 years' experience]. Bosković V; Glisić A; Petković S Srp Arh Celok Lek; 1998; 126(5-6):183-7. PubMed ID: 9863378 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]